Basic Information
Basic information for CPB2-AS1-217-112aa
Peptide Name CPB2-AS1-217-112aa
Genome Position chr13:46121847-46122182[+]
Species Human
Peptide Sequence MSSLSLEVIERLLQAWWEKSQFDRRWRDKREDLSDVAQTGSDLLKRQPWAAGKRSCQETQCRCQQDQKISFLERVPPGRGKPREGAQQRAKLGGGGSTQTEGRATLATSSEY
Peptide Length 112
Unique No (CPB2-AS1-205-112aa,CPB2-AS1-207-112aa,CPB2-AS1-209-112aa,CPB2-AS1-216-112aa)
Grand Average of Hydropathicity -1.0679
Relative Molecular Mass 14726.02
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000235903;CPB2-AS1
Transcript ID/Name ENST00000669053;CPB2-AS1-217
Transcript Length 5586
Coding Ability 0.4697
DNA Sequence Corresponding to Peptide ATGAGTTCCCTGTCACTGGAAGTCATAGAGAGATTGCTCCAGGCATGGTGGGAGAAAAGCCAGTTTGACAGGCGGTGGAGGGATAAGAGGGAAGACTTGAGTGACGTGGCACAAACTGGGTCAGATCTATTAAAGAGGCAGCCCTGGGCAGCTGGCAAGAGATCATGTCAAGAGACACAATGCAGGTGCCAGCAGGACCAGAAGATCAGCTTCTTAGAGCGAGTGCCACCTGGAAGGGGGAAACCAAGGGAAGGGGCACAGCAAAGGGCAAAGCTGGGTGGTGGAGGAAGTACCCAAACAGAGGGAAGAGCCACTCTGGCCACATCAAGTGAATAC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :